Twist Bioscience (TWST) total liabilities

Total liabilities · fiscal 2026
$233.79M

Twist Bioscience (TWST) had total liabilities of $233.79M at the end of fiscal 2026 (September 30, 2026). That is 38.4% higher than the $168.90M of fiscal 2025. Figures as of 19 Nov 2026, 11:31 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total liabilities, fiscal 2026
$233.79M
Change on fiscal 2025
+38.4%
Growth, 5 years
+14.0% a year
Highest on record
$233.79Mfiscal 2026
Lowest on record
$26.73Mfiscal 2018
Fiscal years on record
92018–2026

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Twist Bioscience total liabilities, in more detail

Over the five fiscal years to 2026 total liabilities grew at a compound 14.0% a year. Across the 9 fiscal years on record (2018–2026), the highest was $233.79M in fiscal 2026 and the lowest $26.73M in fiscal 2018.

History · 9 fiscal years

Total liabilities by fiscal year

Twist Bioscience total liabilities, year by year

Twist Bioscience (TWST) total liabilities by fiscal year
Fiscal yearTotal liabilitiesChangeYear ended
2026$233.79M 38.4% up
2025$168.90M 19.3% up
2024$141.63M 7.4% down
2023$152.97M 11.1% down
2022$171.99M 41.8% up
2021$121.28M 93.7% up
2020$62.62M 79.4% up
2019$34.91M 30.6% up
2018$26.73M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest.

How to read it

It is broader than debt: read it against total assets, and remember that for a bank or an insurer customer deposits and policy reserves are liabilities too.

Total liabilities at health care companies of similar size

Total liabilities of Twist Bioscience and comparable companies
CompanyTotal liabilitiesFiscal year
TG Therapeutics TGTX$415.23M2025
Praxis Precision Medicines PRAX$59.77M2025
Twist Bioscience TWST$233.79M2026
Protagonist Therapeutics PTGX$53.48M2025
Krystal Biotech KRYS$114.23M2025
10x Genomics TXG$245.04M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on TWST

Twist Bioscience, figure by figure

Twist Bioscience (TWST) overview: price, valuation and scorecardAll health care companies by market value

Twist Bioscience total liabilities: questions and answers

How large are Twist Bioscience's total liabilities?

Twist Bioscience (TWST) had total liabilities of $233.79M at the end of fiscal 2026 (September 30, 2026). That is 38.4% higher than the $168.90M of fiscal 2025.

What is the growth rate of Twist Bioscience's total liabilities?

Over the five fiscal years to 2026 total liabilities grew at a compound 14.0% a year.

What are the highest and lowest total liabilities figures on record for Twist Bioscience?

Across the 9 fiscal years on record (2018–2026), the highest was $233.79M in fiscal 2026 and the lowest $26.73M in fiscal 2018.

How is Twist Bioscience's total liabilities calculated?

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest. For Twist Bioscience it is on record here for 9 fiscal years, 2018 to 2026.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Twist Bioscience (TWST) total liabilities”, data as of 19 November 2026. https://funkfolio.com/stock/TWST/total-liabilities

Underlying data: the company's filings with the SEC and Yahoo Finance.